Biotech Showcase 2016 - Jan 11-13 San Francisco

  1. 219 Posts.
    I wonder If Viralytics going to be part of Biotech Showcase™ 2016
    We did not participate in 2015.
    Hopefully before 2016 Jan, We already have a deal.
    http://www.ebdgroup.com/bts/past_events/2011/prs_comps.php


    Biotech Showcase™ 2016
    January 11–13, 2016, San Francisco

    http://www.ebdgroup.com/bts/index.php

    Biotech Showcase™ is an investor and partnering conference devoted to providing private and public biotechnology and life sciences companies with an opportunity to present to, and meet with, investors and pharmaceutical executives in one place during the course of one of the industry's largest annual healthcare investor conferences. Investors and biopharmaceutical executives from around the world gather in San Francisco during this critical week which is widely viewed as setting the tone for the coming year.
    Now in its eighth year, this rapidly growing conference features multiple tracks of presenting companies, plenary sessions, workshops, networking, and an opportunity to schedule one-to-one meetings.
    In addition to biopharmaceutical and life science company executives, Biotech Showcase delegates include investors in private and public companies, sector analysts, bankers and industry professionals.
    Biotech Showcase is produced by Demy Colton Life Science Advisors and EBD Group. Both organizations have a long history of producing high quality programs that support the biotechnology and broader life sciences industry.

    Biotech Showcase™ 2015 Highlights
    • 2,100 attendees
    • 4,277 one-to-one meetings
    • 1,041 licensing opportunities posted
    • 1,276 companies
    • 232 company presentations
    • 37 countries represented
    • 14 workshops and panels
    Photos of Biotech Showcase 2015 ►
 
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.

Currently unlisted public company.

arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.